Forward Features Calendar

Intel

Proxy battle at Harley-Davidson revs up

The proxy fight between Harley-Davidson and activist hedge fund H Partners has intensified ahead of the company’s 14 May annual meeting, with major proxy advisory firms split over the future of the motorcycle maker’s board.

Glenview trims CVS stake after strong Q1

Activist hedge fund Glenview Capital has reduced its stake in CVS Health after the insurer reported robust first-quarter results and a raised 2025 earnings outlook, the firm disclosed on Tuesday, according to a report by Reuters.

Tudor Jones sees Trump halving China tariffs

Paul Tudor Jones, founder of macro-focused hedge fund firm Tudor Investment Corporation, expects US President Donald Trump to reduce tariffs on Chinese goods by 50%, but says such a move may not be enough to prevent equity markets from retesting

Japanese drug company Astellas engages with activist Farallon

Activist hedge fund Farallon Capital Management has deepened its involvement with Japanese pharmaceutical giant Astellas Pharma, prompting the company’s leadership to publicly acknowledge ongoing engagement efforts, according to a report by Bloomberg.

Haidar’s macro fund suffers 25% April loss amid market turmoil

Haidar Capital Management’s flagship Jupiter Fund posted a 25% loss in April, marking one of the worst monthly performances in its more than two-decade history, as macro volatility tied to President Donald Trump’s renewed trade war rattled global markets, according

Sandglass Capital appoints Director of Research

Sandglass Capital, an alternative investment firm focused in event-driven investments in emerging market sovereign and corporate credit, has appointed Charles-Antoine Wauters as a Director on the firm’s Investment Team.

Events

08 October, 2026 – 5:00 pm

Directory Listings

Please select one of the below *
Notify Me
Firm Type *
Please select below
Terms & Conditions *
Privacy Policy *